Submit your email to push it up the queue
Wound Care Technologies, Inc., commonly referred to as WCT, is a leading innovator in the wound care industry, headquartered in the United States. Founded in 2001, the company has established itself as a key player in developing advanced wound management solutions, particularly in the areas of surgical and chronic wound care. WCT's flagship product, Dermaclose, is a unique negative pressure wound therapy system that enhances healing while minimising complications. This innovative approach has positioned WCT at the forefront of the market, earning recognition for its commitment to improving patient outcomes. With a strong operational presence across North America and Europe, Wound Care Technologies continues to expand its influence, driven by a dedication to quality and innovation in wound care solutions.
How does Wound Care Technologies, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Wound Care Technologies, Inc.'s score of 62 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Wound Care Technologies, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Baxter International Inc., which may influence its climate commitments and reporting practices. While Wound Care Technologies, Inc. has not established its own reduction targets or climate pledges, it is important to note that emissions data and sustainability initiatives may be inherited from its parent company, Baxter International Inc. This relationship suggests that Wound Care Technologies could potentially align with Baxter's sustainability strategies and targets, although specific details on these initiatives are not provided. As of now, Wound Care Technologies, Inc. has not publicly committed to any Science-Based Targets Initiative (SBTi) reduction targets or other significant climate initiatives. The lack of reported emissions data and reduction commitments highlights an opportunity for the company to enhance its environmental accountability and contribute to broader climate action efforts within the healthcare sector.
Access structured emissions data, company-specific emission factors, and source documents
2002 | 2003 | 2005 | 2006 | 2009 | 2010 | 2011 | 2014 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | 781,365,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | - | - | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Wound Care Technologies, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.